Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34<sup>+ </sup>acute myeloid leukemia cell lines and primary sorted CD34<sup>+ </sup>acute myeloid leukemia cells

<p>Abstract</p> <p>Background</p> <p>Acute myeloid leukemia (AML) is an immunophenotypically heterogenous malignant disease, in which CD34 positivity is associated with poor prognosis. CD34<sup>+ </sup>AML cells are 10-15-fold more resistant to daunorubicin...

Full description

Bibliographic Details
Main Authors: Huang Sheng-Shan, Long Zi-Jie, Zheng Fei-Meng, Xu Duo-Rong, Rao Jia, Wu Xing, Zhou Wei-Hua, Huang Ren-Wei, Liu Quentin
Format: Article
Language:English
Published: BMC 2011-05-01
Series:Journal of Translational Medicine
Online Access:http://www.translational-medicine.com/content/9/1/71
id doaj-9b1cebde405a4908bd70bddc9b2349f8
record_format Article
spelling doaj-9b1cebde405a4908bd70bddc9b2349f82020-11-25T00:56:19ZengBMCJournal of Translational Medicine1479-58762011-05-01917110.1186/1479-5876-9-71Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34<sup>+ </sup>acute myeloid leukemia cell lines and primary sorted CD34<sup>+ </sup>acute myeloid leukemia cellsHuang Sheng-ShanLong Zi-JieZheng Fei-MengXu Duo-RongRao JiaWu XingZhou Wei-HuaHuang Ren-WeiLiu Quentin<p>Abstract</p> <p>Background</p> <p>Acute myeloid leukemia (AML) is an immunophenotypically heterogenous malignant disease, in which CD34 positivity is associated with poor prognosis. CD34<sup>+ </sup>AML cells are 10-15-fold more resistant to daunorubicin (DNR) than CD34<sup>- </sup>AML cells. Curcumin is a major component of turmeric that has shown cytotoxic activity in multiple cancers; however, its anti-cancer activity has not been well studied in DNR-insensitive CD34<sup>+ </sup>AML cells. The aim of this study was to therefore to explore curcumin-induced cytotoxicity in DNR-insensitive CD34<sup>+ </sup>AML cell lines (KG1a, Kasumi-1), DNR-sensitive U937 AML cells, and primary CD34<sup>+ </sup>AML bone-marrow-derived cells.</p> <p>Methods</p> <p>Primary human CD34<sup>+ </sup>cells were isolated from peripheral blood mononuclear cells or bone marrow mononuclear cells using a CD34 MicroBead kit. The growth inhibitory effects of curcumin were evaluated by MTT and colony-formation assays. Cell cycle distribution was examined by propidium iodide (PI) assay. Apoptosis was analyzed by Wright-Giemsa, Hoechst 33342 and Annexin-V/PI staining assays. The change in mitochondrial membrane potential (MMP) was examined by JC-1 staining and flow cytometry. Expression of apoptosis-related proteins was determined by reverse transcription-polymerase chain reaction and Western blotting. Short interfering RNA (siRNA) against <it>Bcl-2 </it>was used in CD34<sup>+ </sup>KG1a and Kasumi-1 cells incubated with/without DNR.</p> <p>Results</p> <p>Curcumin inhibited proliferation and induced apoptosis and G1/S arrest in both DNR-insensitive KG1a, Kasumi-1 and DNR-sensitive U937 cells. Curcumin-induced apoptosis was associated with reduced expression of both Bcl-2 mRNA and protein, subsequent loss of MMP, and activation of caspase-3 followed by PARP degradation. Curcumin synergistically enhanced the cytotoxic effect of DNR in DNR-insensitive KG1a and Kasumi-1 cells, consistent with decreased Bcl-2 expression. Accordingly, siRNA against <it>Bcl-2 </it>increased the susceptibility of KG1a and Kasumi-1 cells to DNR-induced apoptosis. More importantly, curcumin suppressed Bcl-2 expression, selectively inhibited proliferation and synergistically enhanced the cytotoxicity of DNR in primary CD34<sup>+ </sup>AML cells, while showing limited lethality in normal CD34<sup>+ </sup>hematopoietic progenitors.</p> <p>Conclusion</p> <p>Curcumin down-regulates Bcl-2 and induces apoptosis in DNR-insensitive CD34<sup>+ </sup>AML cell lines and primary CD34<sup>+ </sup>AML cells.</p> http://www.translational-medicine.com/content/9/1/71
collection DOAJ
language English
format Article
sources DOAJ
author Huang Sheng-Shan
Long Zi-Jie
Zheng Fei-Meng
Xu Duo-Rong
Rao Jia
Wu Xing
Zhou Wei-Hua
Huang Ren-Wei
Liu Quentin
spellingShingle Huang Sheng-Shan
Long Zi-Jie
Zheng Fei-Meng
Xu Duo-Rong
Rao Jia
Wu Xing
Zhou Wei-Hua
Huang Ren-Wei
Liu Quentin
Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34<sup>+ </sup>acute myeloid leukemia cell lines and primary sorted CD34<sup>+ </sup>acute myeloid leukemia cells
Journal of Translational Medicine
author_facet Huang Sheng-Shan
Long Zi-Jie
Zheng Fei-Meng
Xu Duo-Rong
Rao Jia
Wu Xing
Zhou Wei-Hua
Huang Ren-Wei
Liu Quentin
author_sort Huang Sheng-Shan
title Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34<sup>+ </sup>acute myeloid leukemia cell lines and primary sorted CD34<sup>+ </sup>acute myeloid leukemia cells
title_short Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34<sup>+ </sup>acute myeloid leukemia cell lines and primary sorted CD34<sup>+ </sup>acute myeloid leukemia cells
title_full Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34<sup>+ </sup>acute myeloid leukemia cell lines and primary sorted CD34<sup>+ </sup>acute myeloid leukemia cells
title_fullStr Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34<sup>+ </sup>acute myeloid leukemia cell lines and primary sorted CD34<sup>+ </sup>acute myeloid leukemia cells
title_full_unstemmed Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34<sup>+ </sup>acute myeloid leukemia cell lines and primary sorted CD34<sup>+ </sup>acute myeloid leukemia cells
title_sort curcumin reduces expression of bcl-2, leading to apoptosis in daunorubicin-insensitive cd34<sup>+ </sup>acute myeloid leukemia cell lines and primary sorted cd34<sup>+ </sup>acute myeloid leukemia cells
publisher BMC
series Journal of Translational Medicine
issn 1479-5876
publishDate 2011-05-01
description <p>Abstract</p> <p>Background</p> <p>Acute myeloid leukemia (AML) is an immunophenotypically heterogenous malignant disease, in which CD34 positivity is associated with poor prognosis. CD34<sup>+ </sup>AML cells are 10-15-fold more resistant to daunorubicin (DNR) than CD34<sup>- </sup>AML cells. Curcumin is a major component of turmeric that has shown cytotoxic activity in multiple cancers; however, its anti-cancer activity has not been well studied in DNR-insensitive CD34<sup>+ </sup>AML cells. The aim of this study was to therefore to explore curcumin-induced cytotoxicity in DNR-insensitive CD34<sup>+ </sup>AML cell lines (KG1a, Kasumi-1), DNR-sensitive U937 AML cells, and primary CD34<sup>+ </sup>AML bone-marrow-derived cells.</p> <p>Methods</p> <p>Primary human CD34<sup>+ </sup>cells were isolated from peripheral blood mononuclear cells or bone marrow mononuclear cells using a CD34 MicroBead kit. The growth inhibitory effects of curcumin were evaluated by MTT and colony-formation assays. Cell cycle distribution was examined by propidium iodide (PI) assay. Apoptosis was analyzed by Wright-Giemsa, Hoechst 33342 and Annexin-V/PI staining assays. The change in mitochondrial membrane potential (MMP) was examined by JC-1 staining and flow cytometry. Expression of apoptosis-related proteins was determined by reverse transcription-polymerase chain reaction and Western blotting. Short interfering RNA (siRNA) against <it>Bcl-2 </it>was used in CD34<sup>+ </sup>KG1a and Kasumi-1 cells incubated with/without DNR.</p> <p>Results</p> <p>Curcumin inhibited proliferation and induced apoptosis and G1/S arrest in both DNR-insensitive KG1a, Kasumi-1 and DNR-sensitive U937 cells. Curcumin-induced apoptosis was associated with reduced expression of both Bcl-2 mRNA and protein, subsequent loss of MMP, and activation of caspase-3 followed by PARP degradation. Curcumin synergistically enhanced the cytotoxic effect of DNR in DNR-insensitive KG1a and Kasumi-1 cells, consistent with decreased Bcl-2 expression. Accordingly, siRNA against <it>Bcl-2 </it>increased the susceptibility of KG1a and Kasumi-1 cells to DNR-induced apoptosis. More importantly, curcumin suppressed Bcl-2 expression, selectively inhibited proliferation and synergistically enhanced the cytotoxicity of DNR in primary CD34<sup>+ </sup>AML cells, while showing limited lethality in normal CD34<sup>+ </sup>hematopoietic progenitors.</p> <p>Conclusion</p> <p>Curcumin down-regulates Bcl-2 and induces apoptosis in DNR-insensitive CD34<sup>+ </sup>AML cell lines and primary CD34<sup>+ </sup>AML cells.</p>
url http://www.translational-medicine.com/content/9/1/71
work_keys_str_mv AT huangshengshan curcuminreducesexpressionofbcl2leadingtoapoptosisindaunorubicininsensitivecd34supsupacutemyeloidleukemiacelllinesandprimarysortedcd34supsupacutemyeloidleukemiacells
AT longzijie curcuminreducesexpressionofbcl2leadingtoapoptosisindaunorubicininsensitivecd34supsupacutemyeloidleukemiacelllinesandprimarysortedcd34supsupacutemyeloidleukemiacells
AT zhengfeimeng curcuminreducesexpressionofbcl2leadingtoapoptosisindaunorubicininsensitivecd34supsupacutemyeloidleukemiacelllinesandprimarysortedcd34supsupacutemyeloidleukemiacells
AT xuduorong curcuminreducesexpressionofbcl2leadingtoapoptosisindaunorubicininsensitivecd34supsupacutemyeloidleukemiacelllinesandprimarysortedcd34supsupacutemyeloidleukemiacells
AT raojia curcuminreducesexpressionofbcl2leadingtoapoptosisindaunorubicininsensitivecd34supsupacutemyeloidleukemiacelllinesandprimarysortedcd34supsupacutemyeloidleukemiacells
AT wuxing curcuminreducesexpressionofbcl2leadingtoapoptosisindaunorubicininsensitivecd34supsupacutemyeloidleukemiacelllinesandprimarysortedcd34supsupacutemyeloidleukemiacells
AT zhouweihua curcuminreducesexpressionofbcl2leadingtoapoptosisindaunorubicininsensitivecd34supsupacutemyeloidleukemiacelllinesandprimarysortedcd34supsupacutemyeloidleukemiacells
AT huangrenwei curcuminreducesexpressionofbcl2leadingtoapoptosisindaunorubicininsensitivecd34supsupacutemyeloidleukemiacelllinesandprimarysortedcd34supsupacutemyeloidleukemiacells
AT liuquentin curcuminreducesexpressionofbcl2leadingtoapoptosisindaunorubicininsensitivecd34supsupacutemyeloidleukemiacelllinesandprimarysortedcd34supsupacutemyeloidleukemiacells
_version_ 1725227684086153216